Farrell Hair Replacement - Voted # 1 In The World For 5 Consecutive Years ! 
    

SPECIAL INTEREST GROUPS

Hair Multiplication & Research Waseda's Regimen Members Area Scientific Discussion Hair Transplant
Hair Replacement
Topical Treatments Internal Drugs or Supplements Women's 
Forum
Support 
Miscellaneous
Gallery
Links
 

HairSite - Hair Loss & Hair Care Forums
Topic 580 - GlaxoSmithKline Dutasteride (Avolve / Duagen) Hair Loss Discussion Group - forum 25

[ Men's Archives | Women's Archives | Contents | Search | Post | Reply | Next | Previous | Up ]


The lastest drug approvals

From: ButtGaser
Date: 6/21/2002
Time: 7:25:47 PM
Remote Name: 12.245.42.248

Comments

Hi, no Dutasteride/Avolve/Duagen/Dutasteride/or GI198745 here-

June 21, 2002

New and Generic Drug Approvals [Includes Drug Label and Approval Letter] http://www.fda.gov/cder/approval/index.htm Accutane (isotretinoin) Capsules, Hoffmann-La Roche Inc. Angiomax (bivalirudin) Injection, The Medicines Company Cenestin (synthetic conjugated estrogens, A) Tablets, Barr Laboratories, Inc. Crixivan (Indinavir Sulfate) Capsules, Merck Research Laboratories Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, CorePharma LLC Dopamine Hydrochloride and 5% Dextrose Injection, USP, Baxter Healthcare Corporation Geodon (Ziprasidone Mesylate) Injection, Pfizer, Inc. Isovue (iopamidol injection) and Isovue Multipack (iopamidol injection-pharmacy bulk pack), Bracca Diagnostics Inc. Lotrel (amlodipine and benazepril HCl) Capsules, Novartis Pharmaceuticals Corporation Ophthetic (proparacaine HCl ophthalmic solution), Allergan, Inc. Serzone (nefazodone hydrochloride) Tablets, Bristol-Myers Squibb Company Skelaxin (metaxalone) Tablets, Elan Pharmaceuticals, Inc. Tramadol Hydrochloride Tablets, Caraco Pharmaceutical Laboratories, Ltd. Tramadol Hydrochloride Tablets, Purepac Pharmaceutical Co. Tramadol Hydrochloride Tablets, Teva Pharmaceuticals Tramadol Hydrochloride Tablets, CorePharma LLC Tramadol Hydrochloride Tablets, Mutual Pharmaceutical Co. Tramadol Hydrochloride Tablets, Mylan Pharmaceuticals, Inc. Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, Glaxo SmithKline

June 20, 2002

Approved Active Moieties to which FDA has Issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act http://www.fda.gov/cder/pediatric/wrlist.htm Drug Shortages http://www.fda.gov/cder/drug/shortages/default.htm Current Drug Shortage: Amidate (Etomidate Injection) 2 mg/mL http://www.fda.gov/cder/drug/shortages/default.htm#Current Pediatric Exclusivity Statistics as of May 1, 2002 http://www.fda.gov/cder/pediatric/wrstats.htm Spectrum of Diseases/Conditions Written Requests as of May 1, 2002 http://www.fda.gov/cder/pediatric/specdis.htm

June 19, 2002

Bar Code Label Requirements for Human Drug Products; Notice of Public Meeting. Meeting on July 26, 2002. [HTML] http://www.fda.gov/OHRMS/DOCKETS/98fr/061802a.htm or [PDF] http://www.fda.gov/OHRMS/DOCKETS/98fr/061802a.pdf CDER Organization Charts Center for Drug Evaluation Research Organizational Chart http://www.fda.gov/cder/cderorg/cder.pdf Office of Center Director http://www.fda.gov/cder/cderorg/ocd.pdf Office of Pharmaceutical Sciences http://www.fda.gov/cder/cderorg/ops.pdf

Office of Pharmacoepidemiology and Statistical Science http://www.fda.gov/cder/cderorg/OPSS.PDF Office of New Drugs http://www.fda.gov/cder/cderorg/OND.PDF New and Generic Drug Approvals [Includes Drug Label and Approval Letter] http://www.fda.gov/cder/approval/index.htm Alphagan (brimonidine tartrate ophthalmic solution), 0.5, 0.2 & (P) 0.15%, Drug Approval Package Betapace (sotalol hydrochloride) Tablets, Drug Approval Package Infuvite Pediatric (Multiple Vitamins for Infusion) IV, Drug Approval Package Levo-T (levothyroxine sodium tablets, USP), Drug Approval Package Navelbine (Vinorelbine) Injection, Drug Approval Package Tequin (Gatifloxacin) Tablets & Injection, Drug Approval Package

June 18, 2002

Evaluation of Written Prescription Information Provided in Community Pharmacies, 2001. http://www.fda.gov/cder/reports/prescriptionInfo/default.htm New and Generic Drug Approvals [Includes Drug Label and Approval Letter] http://www.fda.gov/cder/approval/index.htm Aggrastat (tirofiban hydrochloride) Injection & Premixed Injection, Merck & Co., Inc. Colazal (balsalazide disodium) Capsules, Salix Pharmaceuticals, Inc. Doryx (coated doxycycline hyclate pellets) Capsules, F. H. Faulding & Co, Ltd. Lanoxin (digoxin) Injection, GlaxoSmithKline Monodox (doxycycline monohydrate) Capsules, Watson Laboratories, Inc. Vibramycin Monohydrate (doxycycline monohydrate) Oral Suspension, Vibramycin Capsules, Intravenous, Vibramycin Calcium (doxycycline calcium oral suspension) Syrup, Vibra-Tabs (doxycycline hyclate) Film Coated Tablets, Pfizer, Inc. Nonprescription Drugs Advisory Committee Roster http://www.fda.gov/cder/audiences/acspage/nonprescriptionroster1.htm Warning Letters and Notice of Violation Letters to Pharmaceutical Companies http://www.fda.gov/cder/warn/warn2002.htm

June 17, 2002

Office of Generic Drugs Approvals http://www.fda.gov/cder/ogd/approvals/AP0502.htm First-Time Generics http://www.fda.gov/cder/ogd/approvals/1stgen0502.htm Tentative Approvals http://www.fda.gov/cder/ogd/approvals/TA0502.htm Paragraph IV Drug Patent Certifications http://www.fda.gov/cder/ogd/ppiv.htm Office Directory http://www.fda.gov/cder/ogd/ogddir.htm Approved Active Moieties to which FDA has Granted Exclusivity for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act http://www.fda.gov/cder/pediatric/exgrant.htm Drug Safety and Risk Management Committee Charter (Updated) http://www.fda.gov/cder/audiences/acspage/DSaRMcharter.htm Patent Term Extension and New Patents Docket Number *95S-0117 http://www.fda.gov/cder/orange/docket.pdf Studies Breakdown Report for Issued Written Requests as of 6/1/2002: Pediatric Exclusivity http://www.fda.gov/cder/pediatric/breakdown.htm

All of you should have a subscription to this CDER Weekly- It is how I first found out that Dutasteride was FDA approved. However, I'm not sure if it deals with sNDA's at all, but be sure to pay close attention to this detail- Tentative Approvals http://www.fda.gov/cder/ogd/approvals/TA0502.htm

-ButtGaser


Last changed: April 17, 2007

SPECIAL INTEREST GROUPS

Hair Multiplication & Research Waseda's Regimen Members Area Scientific Discussion Hair Transplant
Hair Replacement
Topical Treatments Internal Drugs / Supplements Women's 
Forum
Support 
Miscellaneous
Gallery
Links
 

 

Site Index
HOME | Headlines | Male Forums | Female Forums | Library | Research | WasedaShopping  | Consumer Education | Consumer Alert Hair Replacement | Hair Transplant  | Topical Treatment | Alternative Treatment | Oral Treatment | Testimonials | Perms & Relaxers | Hair Color | Patents  | Live Help | Book Club | Testimonials Input Sheet  |  Polls | Gallery | Quality Control |

 

© Copyright 1997 - 2002  TSE Publishing, Inc. All rights reserved.
No part of this website can be reproduced. Contact info: HairSite@aol.com